SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017514
Filing Date
2020-08-11
Accepted
2020-08-11 16:02:54
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20200630_10q.htm 10-Q 596418
2 EXHIBIT 10.1 ex_198797.htm EX-10.1 54347
3 EXHIBIT 31.1 ex_197539.htm EX-31.1 13755
4 EXHIBIT 31.2 ex_197540.htm EX-31.2 13797
5 EXHIBIT 32.1 ex_197541.htm EX-32.1 4965
6 EXHIBIT 32.2 ex_197542.htm EX-32.2 5341
13 chart01.jpg GRAPHIC 32560
  Complete submission text file 0001437749-20-017514.txt   3518578

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dmac-20200630.xml EX-101.INS 641130
8 XBRL TAXONOMY EXTENSION SCHEMA dmac-20200630.xsd EX-101.SCH 44148
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20200630_cal.xml EX-101.CAL 31601
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20200630_def.xml EX-101.DEF 261919
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20200630_lab.xml EX-101.LAB 223913
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20200630_pre.xml EX-101.PRE 287812
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 201092400
SIC: 2834 Pharmaceutical Preparations